Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2002 by Triangle Pharmaceuticals.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Triangle Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00044135
First received: August 20, 2002
Last updated: June 23, 2005
Last verified: November 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given